Heyu Biological Technology Corporation
HYBT · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $241 | $896 | $11 | $4 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $53 | $743 | $4 | $30 |
| Inventory | $0 | $14 | $14 | -$26 |
| Other Curr. Assets | $7,833 | $2,308 | $3 | $30 |
| Total Curr. Assets | $8,126 | $3,961 | $32 | $37 |
| Property Plant & Equip (Net) | $17 | $3 | $0 | $56 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $3 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $49,308 | $46,248 | $0 | $0 |
| Total NC Assets | $49,325 | $46,255 | $0 | $56 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $57,451 | $50,216 | $32 | $94 |
| Liabilities | – | – | – | – |
| Payables | $12 | $651 | $16 | $17 |
| Short-Term Debt | $235 | $0 | $0 | $58 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $435 | $472 |
| Other Curr. Liab. | $6,444 | -$247 | $1,554 | $1,356 |
| Total Curr. Liab. | $6,692 | $1,055 | $2,005 | $1,903 |
| LT Debt | $6,563 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $5,423 | $8,672 | $0 | $0 |
| Total NC Liab. | $11,986 | $8,672 | $451 | $0 |
| Other Liabilities | $0 | $0 | -$451 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $18,678 | $9,728 | $2,005 | $1,903 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $519 | $519 | $1,032 | $1,032 |
| Retained Earnings | -$1,292 | -$813 | -$19,887 | -$19,621 |
| AOCI | -$366 | $876 | -$52 | -$176 |
| Other Equity | $39,906 | $39,905 | $17,149 | $17,149 |
| Total Equity | $38,768 | $40,488 | -$1,757 | -$1,615 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $6 | $0 | -$215 | -$195 |
| Total Liab. & Tot. Equity | $57,451 | $50,216 | $32 | $94 |
| Net Debt | $6,558 | -$896 | -$11 | $54 |